Cargando…
Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study
BACKGROUND: Shared care agreements between clinical pharmacists and physicians can improve suboptimal lithium monitoring in in- and outpatient settings. However, it is unknown whether incorporating community pharmacists in such agreements can also improve lithium monitoring in an outpatient setting....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393139/ https://www.ncbi.nlm.nih.gov/pubmed/35831730 http://dx.doi.org/10.1007/s11096-022-01420-9 |
_version_ | 1784771205278990336 |
---|---|
author | Brouwer, Jurriaan M. J. L. Risselada, Arne J. de Wit, Marinka Lubberts, Janniek Westerhuis, Henrieke Doornbos, Bennard Mulder, Hans |
author_facet | Brouwer, Jurriaan M. J. L. Risselada, Arne J. de Wit, Marinka Lubberts, Janniek Westerhuis, Henrieke Doornbos, Bennard Mulder, Hans |
author_sort | Brouwer, Jurriaan M. J. L. |
collection | PubMed |
description | BACKGROUND: Shared care agreements between clinical pharmacists and physicians can improve suboptimal lithium monitoring in in- and outpatient settings. However, it is unknown whether incorporating community pharmacists in such agreements can also improve lithium monitoring in an outpatient setting. AIM: To assess the necessity for a shared care agreement for lithium monitoring in our region by investigating: intervention rates by community pharmacists and whether those are sufficient; lithium monitoring by physicians in ambulatory patients; the extent of laboratory parameter exchange to community pharmacists. METHOD: Patient files of lithium users were surveyed in a retrospective cohort study among 21 community pharmacies in the Northern Netherlands. Outcome was the intervention rate by community pharmacists and whether those were deemed sufficient by an expert panel. Additionally, we investigated both the percentages of patients monitored according to current guidelines and of laboratory parameters exchanged to community pharmacists. RESULTS: 129 patients were included. Interventions were performed in 64.4% (n = 29), 20.8% (n = 5), and 25.0% (n = 1) of initiations, discontinuations, and dosage alterations of drugs interacting with lithium, respectively. The expert panel deemed 40.0% (n = 14) of these interventions as “insufficient”. Physicians monitored 40.3% (n = 52) of the patients according to current guidelines for lithium serum levels and kidney functions combined. Approximately half of the requested laboratory parameters were available to the community pharmacist. CONCLUSION: Intervention rates by community pharmacists and lithium monitoring by physicians can be improved. Therefore, a shared care agreement between community pharmacists, clinical pharmacists, and physicians is needed to improve lithium monitoring in ambulatory patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-022-01420-9. |
format | Online Article Text |
id | pubmed-9393139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-93931392022-08-23 Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study Brouwer, Jurriaan M. J. L. Risselada, Arne J. de Wit, Marinka Lubberts, Janniek Westerhuis, Henrieke Doornbos, Bennard Mulder, Hans Int J Clin Pharm Research Article BACKGROUND: Shared care agreements between clinical pharmacists and physicians can improve suboptimal lithium monitoring in in- and outpatient settings. However, it is unknown whether incorporating community pharmacists in such agreements can also improve lithium monitoring in an outpatient setting. AIM: To assess the necessity for a shared care agreement for lithium monitoring in our region by investigating: intervention rates by community pharmacists and whether those are sufficient; lithium monitoring by physicians in ambulatory patients; the extent of laboratory parameter exchange to community pharmacists. METHOD: Patient files of lithium users were surveyed in a retrospective cohort study among 21 community pharmacies in the Northern Netherlands. Outcome was the intervention rate by community pharmacists and whether those were deemed sufficient by an expert panel. Additionally, we investigated both the percentages of patients monitored according to current guidelines and of laboratory parameters exchanged to community pharmacists. RESULTS: 129 patients were included. Interventions were performed in 64.4% (n = 29), 20.8% (n = 5), and 25.0% (n = 1) of initiations, discontinuations, and dosage alterations of drugs interacting with lithium, respectively. The expert panel deemed 40.0% (n = 14) of these interventions as “insufficient”. Physicians monitored 40.3% (n = 52) of the patients according to current guidelines for lithium serum levels and kidney functions combined. Approximately half of the requested laboratory parameters were available to the community pharmacist. CONCLUSION: Intervention rates by community pharmacists and lithium monitoring by physicians can be improved. Therefore, a shared care agreement between community pharmacists, clinical pharmacists, and physicians is needed to improve lithium monitoring in ambulatory patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-022-01420-9. Springer International Publishing 2022-07-13 2022 /pmc/articles/PMC9393139/ /pubmed/35831730 http://dx.doi.org/10.1007/s11096-022-01420-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Brouwer, Jurriaan M. J. L. Risselada, Arne J. de Wit, Marinka Lubberts, Janniek Westerhuis, Henrieke Doornbos, Bennard Mulder, Hans Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study |
title | Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study |
title_full | Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study |
title_fullStr | Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study |
title_full_unstemmed | Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study |
title_short | Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study |
title_sort | lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393139/ https://www.ncbi.nlm.nih.gov/pubmed/35831730 http://dx.doi.org/10.1007/s11096-022-01420-9 |
work_keys_str_mv | AT brouwerjurriaanmjl lithiumsurveillancebycommunitypharmacistsandphysiciansinambulatorypatientsaretrospectivecohortstudy AT risseladaarnej lithiumsurveillancebycommunitypharmacistsandphysiciansinambulatorypatientsaretrospectivecohortstudy AT dewitmarinka lithiumsurveillancebycommunitypharmacistsandphysiciansinambulatorypatientsaretrospectivecohortstudy AT lubbertsjanniek lithiumsurveillancebycommunitypharmacistsandphysiciansinambulatorypatientsaretrospectivecohortstudy AT westerhuishenrieke lithiumsurveillancebycommunitypharmacistsandphysiciansinambulatorypatientsaretrospectivecohortstudy AT doornbosbennard lithiumsurveillancebycommunitypharmacistsandphysiciansinambulatorypatientsaretrospectivecohortstudy AT mulderhans lithiumsurveillancebycommunitypharmacistsandphysiciansinambulatorypatientsaretrospectivecohortstudy |